Literature DB >> 29309730

Exploration of Blood Coagulation of N-Alkyl Chitosan Nanofiber Membrane in Vitro.

Xiaoyan Wang1,2, Jing Guan1, Xupin Zhuang2, Zhihong Li1, Shujie Huang1, Jian Yang1, Changjun Liu1, Fan Li1, Feng Tian1, Jimin Wu1, Zhan Shu1.   

Abstract

N-Alkylated chitosan (NACS) may improve the blood clotting efficiency of chitosan (CS). To study its blood coagulation capability, a series of NACSs with various carbon chain lengths and degrees of substitution (DS) of alkyl groups were synthesized and characterized by FTIR, NMR, elemental analysis, and X-ray diffraction (XRD). The corresponding NACS nanofiber membranes (NACS-NM) were subsequently fabricated by electronic spinning technique. SEM, XRD, DSC, surface area, porosity, contact angle, blood absorption, and mechanical properties were used to characterize the CS-NM/NACS-NM. Moreover, cytotoxicity, coagulation, activated partial thromboplastin time, plasma prothrombin time, thrombin time, and platelet aggregation tests were performed to evaluate the biocompatibility and blood coagulation properties of NACS-NM. The results showed that NACS-NM was not cytotoxic. NACS-NM with DS of 19.25% for N-hexane CS (CS6b), 17.87% for N-dodecane CS (CS12b), and 8.97% for N-octadecane CS (CS18a) exhibited good blood clotting performance. Moreover, NACS-NMs favored the activation of coagulation factors and platelets. In addition, intracellular Ca2+ was not related to platelet activation. The above results suggested that NACS-NM would be an effective hemostatic agent.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29309730     DOI: 10.1021/acs.biomac.7b01492

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  5 in total

Review 1.  Technology Advancements in Blood Coagulation Measurements for Point-of-Care Diagnostic Testing.

Authors:  Mohammad Mohammadi Aria; Ahmet Erten; Ozlem Yalcin
Journal:  Front Bioeng Biotechnol       Date:  2019-12-11

2.  Bio-inspired, bio-degradable adenosine 5'-diphosphate-modified hyaluronic acid coordinated hydrophobic undecanal-modified chitosan for hemostasis and wound healing.

Authors:  Yihao Liu; Haoyi Niu; Chengwei Wang; Xiaoxiao Yang; Wentao Li; Yuxin Zhang; Xiaojun Ma; Yuanjing Xu; Pengfei Zheng; Jinwu Wang; Kerong Dai
Journal:  Bioact Mater       Date:  2022-01-29

3.  Evaluation of Novel Tranexamic Acid/Montmorillonite Intercalation Composite, as a New Type of Hemostatic Material.

Authors:  Fei Ma; Shujing Sui; Zhiyuan Yang; Tong Ye; Lei Yang; Peng Han; Hui Gan; Zhuona Wu; Ruolan Gu; Xiaoxia Zhu; Fei Li; Zhiyun Meng; Zhiping Jiang; Guifang Dou
Journal:  Biomed Res Int       Date:  2022-02-28       Impact factor: 3.411

4.  Preparation of Chitosan/Clay Composites for Safe and Effective Hemorrhage Control.

Authors:  Zhiyuan Yang; Tong Ye; Fei Ma; Xinhong Zhao; Lei Yang; Guifang Dou; Hui Gan; Zhuona Wu; Xiaoxia Zhu; Ruolan Gu; Zhiyun Meng
Journal:  Molecules       Date:  2022-04-15       Impact factor: 4.927

5.  Microchannelled alkylated chitosan sponge to treat noncompressible hemorrhages and facilitate wound healing.

Authors:  Xinchen Du; Le Wu; Hongyu Yan; Zhuyan Jiang; Shilin Li; Wen Li; Yanli Bai; Hongjun Wang; Zhaojun Cheng; Deling Kong; Lianyong Wang; Meifeng Zhu
Journal:  Nat Commun       Date:  2021-08-05       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.